Skip to content

Biotrace-N, Ns, 410 and Rt

by Msb, Ltd.

510(k) K944496

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK944496 Date16 May 1996ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DRX
FDA applicant
Msb , Ltd.
Device Class
Class II
Regulation
21 CFR Part 870.2360
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 21 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

BIOTRACE-N, NS, 410 AND RT is an electrode for electrocardiograph use, classified under product code DRX and categorized within the cardiovascular medical specialty. It is a Class II device subject to special controls, as determined by its regulatory classification.

The device received FDA 510(k) clearance K944496 on May 16, 1996, following a traditional review process, and was found substantially equivalent to a predicate device. It was submitted by Msb, Ltd. of Marlborough, Wiltshire, United Kingdom.

Other devices from Msb, Ltd.

Questions

AI-generated answers, 21 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the BIOTRACE-N, NS, 410 AND RT electrode used for?

    The BIOTRACE-N, NS, 410 AND RT electrode is designed for use with electrocardiograph (ECG) systems to monitor cardiac electrical activity, falling under the cardiovascular medical specialty as indicated by its product code DRX and regulatory classification.

  • How was the BIOTRACE-N, NS, 410 AND RT electrode cleared for market?

    The device received FDA 510(k) clearance under number K944496 on May 16, 1996, following a traditional review process, and was determined to be substantially equivalent to a legally marketed predicate device, which is the basis for its Class II classification with special controls.

  • Who manufactures the BIOTRACE-N, NS, 410 AND RT electrode and where are they located?

    The BIOTRACE-N, NS, 410 AND RT electrode is manufactured by Msb, Ltd., located at Hilldrop Ln., Ramsbury, Marlborough, Wiltshire, SN8 2RB, United Kingdom, as specified in the device’s authorization and submission details.